Author

Martin C. Sadowski

University of BernORCID 0000-0002-5267-1442Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Abdulloh K Bihi· 1 shared Anja RockstrohiD· 1 shared Anna BattistellaiD· 1 shared Aurel A. PerreniD· 1 shared Charles L. BidgoodiD· 1 shared Colleen C. NelsoniD· 1 shared Ilaria MarinoniiD· 1 shared Janine Straub· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdulloh K Bihi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 31, 2025

Dual inhibition of lactate transporters MCT1 and MCT4 in pancreatic neuroendocrine tumors targets metabolic heterogeneity and functional redundancy

Konstantin Bräutigam, Janine Straub, Abdulloh K Bihi…·Aurel A. Perren

The paper investigates MCT1 and MCT4 expression in PanNETs, showing their role in metabolic heterogeneity and functional redundancy, and demonstrates that dual inhibition targets tumor aggressiveness.

6 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologyCell Death and DiseasePeer-reviewedJul 18, 2024

Valine Catabolism Drives Bioenergetic and Lipogenic Fuel Plasticity in Prostate Cancer

Charles L. Bidgood, Lisa K. Philp, Anja Rockstroh…·Jennifer H. Gunter

This study identifies valine catabolism as a key driver of bioenergetic and lipogenic flexibility in prostate cancer, with potential therapeutic implications.

31 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky